-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Liu Chunmei 1, Wang Chunmei 2, Wu Lishan 2, Zhou Hongwei 2, Deng Fang 2, Shi Mingchao 2, Gao Peihong 2, Chen Wei 2
Author Unit: 1.
Changchun Obstetrics and Gynecology Hospital 2.
Department of Radiology, Bethune First Hospital, Jilin University
Heparin anticoagulation therapy is the first choice for patients with CVST, and systemic anticoagulation can effectively prevent the formation of fresh thrombi
.
In recent years, intravascular interventional therapy has also been increasingly applied to patients with refractory CVST.
Cerebral venous sinus thrombosis (cerebral venous sinus thrombosis) is a rare cerebrovascular disease with serious complications.
Its clinical manifestations are diverse and lack specificity
.
The disease often occurs in young and middle-aged people, especially those whose blood is in a hypercoagulable state due to exogenous hormone therapy, pregnancy, and postpartum
1.
Clinical data
The patient, a 55-year-old female, was admitted to the hospital with headache, dizziness and blurred vision for 20 days, worsened by 3 days
.
The patient took orally refluxed drugs due to vaginal bleeding within the past 1 year (specificity unknown)
After treatment for a period of time, the patient gradually became blind and underwent lumbar puncture to measure intracranial pressure> 400mmH2O, which indicated that the patient's condition had deteriorated
.
A positive urine occult blood test indicates a tendency to hemorrhage
2.
Leave a message here
